CAS RN: 1012058-78-4

Sorafenib related compound 10

Product Availability

Choose a grade to view its available package options.

1 package records0 with current stock1 grade group
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250416 5mg / 10mg Out of stock 5-7 business days Inquiry
  • Product code: starshine_CAS1012058-78-4
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1012058-78-4 / 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]pyridine-2-carboxylic acid

4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)picolinic acid | Sorafenib Hydroxydemethylamine | Sorafenib metabolite M6

Standard CAS: 1012058-78-4 Multi CAS: No

Basic Information

CAS
1012058-78-4
Multi CAS
No
Molecular Formula
C20H13ClF3N3O4
Molecular Weight
451.800000
Exact Mass
451.054668
SMILES
C1=CC(=CC=C1NC(=O)NC2=CC(=C(C=C2)Cl)C(F)(F)F)OC3=CC(=NC=C3)C(=O)O
InChI
InChI=1S/C20H13ClF3N3O4/c21-16-6-3-12(9-15(16)20(22,23)24)27-19(30)26-11-1-4-13(5-2-11)31-14-7-8-25-17(10-14)18(28)29/h1-10H,(H,28,29)(H2,26,27,30)
InChIKey
IPCWVRAYBZXUMM-UHFFFAOYSA-N
Synonyms
4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)picolinic acid Sorafenib Hydroxydemethylamine Sorafenib metabolite M6 4-(4-((4-Chloro-3-(trifluoromethyl)phenyl)carbamoylamino)phenoxy)pyridine-2-carboxylic acid O9ZAV58U4C

Computed Properties

Structural Parameters

Heavy atom count
31
Aromatic heavy atom count
18
Fraction Csp3
0.05
Rotatable bonds
5
H-bond acceptors
4
H-bond donors
3
Molar refractivity
106.81
TPSA
100.55

LogP / Solubility

WLOGP
5.89
MLOGP
5.21
XLogP3
4.3
Consensus LogP
5.13
Log S (ESOL)
-6.45
Class (ESOL)
Insoluble
Log S (Ali)
-7.52
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-8.08
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.3

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
2.5

Get In Touch

Contact Us